Fique esperto e seja bem sucedido como Oleg Taktarov! Início brilhante entre os embaixadores da marca InstaSpot!

Ator, hexacampeão do UFC e um verdadeiro herói!
Um homem de sucesso. Um homem que mostra o nosso caminho.
O segredo por trás do sucesso de Taktarov é um movimento constante em direção ao objetivo.
Revele todos os lados do seu talento!
Descubra, tente, falhe, mas nunca pare!

I InstaSpot. Sua história de sucesso começa aqui!

For Traders

Charts

#DVAX

#DVAX (Dynavax Technologies Corporation). Taxa de câmbio e gráficos online.

#DHR Voltar à lista de instrumentos #DXCM

Conversor de moedas

10.89 USD
09 Dec 2025 22:59

$-0.02
(-0.18%)

Fechamento anterior

$10.96

Abrir

$10.93

Máximo do dia

$11.12

Mínimo do dia

$10.85

Alta de 52-semanas

$11.28

Baixa de 52-semana

$10.62

Baixar arquivo

Open the chart in full screen view

Baixar arquivo

Open the chart in full screen view

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.

The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.

In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.

Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.

Dynavax Technologies Corporation’s shares and what affects their price

Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.

Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.

What to pay attention to when trading the company’s shares:

Long-term growth prospects are driven by a large number of innovative developments;
The target price for the stock is several times higher than the current one, ranging between $45.5 and $48, according to forecasts;
Adjuvant technology is an advantage for the company since these additional substances significantly enhance the effect of the vaccines.

InstaSpot – milhões de clientes confiam em nós! Sua escolha fala mais alto que as palavras!

Fique esperto e seja bem sucedido como Oleg Taktarov! Início brilhante entre os embaixadores da marca InstaSpot!

#DVAX (Dynavax Technologies Corporation). Taxa de câmbio e gráficos online.

Conversor de moedas

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation’s shares and what affects their price